Proteomics

Dataset Information

0

CSN5i-3 induces degradation of selective CRL substrate receptors and accumulation of CRL substrates


ABSTRACT: In this study, we used quantitative proteomics mass spectrometry with 16-plex TMT labeling to compare individual protein levels of DMSO and 1 μM CSN5i-3-treated K562 cells for 2, 8, and 24 hours. CSN5i-3 is a selective and potent inhibitor of Cop9 Signalosome (CSN), which regulates the activity of Cullin-RING E3 ubiquitin ligases (CRLs). CSN5i-3 treatment resulted in reduced CSN activity, and consequently increased cullin neddylation and constitutively active CRL. Gene Ontology analysis of the changed proteins between DMSO- and CSN5i-3-treated samples showed the enrichment of CSN subunits, cell cycle and chromosome-related components, and phosphatase complex, which include multiple CSN subunits (e.g., CSN7B and CSN5), components of CRLs, especially CRL SRs (e.g., SKP2, ELOA and DCAF1/VPRBP), and known substrates of CRLs (e.g., MAGEA6, GLUL, and RHOB). Indeed, eight out of the top 20 most decreased proteins were CRL adaptor and substrate receptors, two out of the top 20 were E2 proteins (CDC34/UBE2R1 and UBE2R2), and two were CSN subunits. Eight out of the top 20 most increased proteins were reported CRL substrates.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

DISEASE(S): Chronic Myeloid Leukemia

SUBMITTER: Brett Lomenick  

LAB HEAD: Spiros D Garbis

PROVIDER: PXD027862 | Pride | 2022-09-05

REPOSITORIES: Pride

Similar Datasets

2011-10-26 | E-GEOD-19085 | biostudies-arrayexpress
2011-10-27 | GSE19085 | GEO
2019-09-13 | PXD013001 | Pride
2019-09-13 | PXD013018 | Pride
2020-02-04 | PXD014673 | Pride
2023-09-02 | PXD039649 | Pride
2009-03-24 | GSE14088 | GEO
2009-03-23 | E-GEOD-14088 | biostudies-arrayexpress
2013-10-23 | E-GEOD-51563 | biostudies-arrayexpress
2017-04-13 | MSV000080917 | MassIVE